Healthcare News and Headlines
Healthcare News and Headlines
Only three of north‑central Florida’s 14 counties have full obstetric coverage, while five are maternity‑care deserts affecting roughly 3,400 women of child‑bearing age. Hospital closures have left 18 of the state’s 21 rural hospitals without obstetric services. In response, the University of Florida launched an OB/GYN Mobile Outreach Clinic in February 2025, delivering comprehensive prenatal, postpartum and preventive care free of charge. By the end of its first year the clinic completed 616 visits for 194 women, illustrating a practical solution to rural maternal‑health gaps.
Universal Health Services (UHS) announced an $835 million acquisition of virtual behavioral‑health platform Talkspace at $5.25 per share, a 10% premium. The deal brings roughly 6,000 clinicians into UHS’s network, addressing chronic staffing shortages that have limited growth in its behavioral‑health...
The FDA’s Oncologic Drugs Advisory Committee will convene on April 30 to evaluate AstraZeneca’s oral SERD camizestrant for first‑line HR‑positive, HER2‑negative breast cancer and its AKT inhibitor Truqap for metastatic hormone‑sensitive prostate cancer. Camizestrant’s Phase 3 SERENA‑6 trial reported a 56% reduction...
Prime Minister Narendra Modi highlighted healthcare, education and tourism as pillars for a developed India, urging reforms and stakeholder collaboration. He stressed expanding telemedicine and training youth for the burgeoning "care economy," which could employ 60 million people and generate a...
Seattle’s fire department relies on for‑profit contractor American Medical Response (AMR) for most 911 transports and introduced a Nurse Navigation program in 2022 to triage low‑acuity calls via a remote nurse line. The program exempts nurse‑ordered ambulance rides from standard...
Oregon Senate Bill 1575 aims to stop hospice fraud by barring operators with prior misconduct from opening in the state. The bill imposes a temporary moratorium on new hospice licenses while licensing rules are revised. It requires the Oregon Health...
The FDA rejected Incyte’s supplemental application to add non‑small cell lung cancer to Zynyz’s label, citing compliance failures at Novo Nordisk’s Catalent‑owned Indiana manufacturing plant. The agency’s complete response letter pinpointed inspection findings at the site as the sole approvability...
Amgen’s Lumakras earned accelerated FDA approval in 2021 as the first KRAS‑targeted therapy, but sales have been modest, reaching $92 million in Q4 2025 with only an 8% year‑over‑year increase. A second G12C inhibitor, Krazati, entered the market in 2022, narrowing Amgen’s...
The Healthcare Justice Coalition, representing the liquidation trusts of two bankrupt physician‑staffing firms, has filed an antitrust lawsuit against the Blue Cross Blue Shield Association and its 33 carriers, alleging coordinated actions that inflate provider costs. The complaint seeks an...
The GAO analyzed 2024 NAIC enrollment data and found that private stand‑alone dental and vision insurance markets are highly concentrated, with the three largest insurers capturing 38‑98% of dental and 41‑96% of vision group market enrollment across states. Median market...
Health Secretary Robert F. Kennedy Jr. announced plans to direct the FDA to move roughly 14 previously banned peptides from the agency’s category 2 list to category 1, allowing pharmacy compounding and physician prescribing. The change would reverse a 2024 ban on...
Johns Hopkins’ Artificial Intelligence and Technology Collaboratory for Aging Research (JH AITC) has distributed $20 million in National Institute on Aging funds to 45 states, D.C., Puerto Rico and the U.S. Virgin Islands, spawning 42 peer‑reviewed papers, seven market‑ready products and $11.7 million...
Roche’s oral SERD giredestrant failed to meet its primary endpoint in the phase 3 persevERA trial, showing no significant improvement over letrozole when combined with palbociclib in first‑line HR‑positive, HER2‑negative advanced breast cancer. The company now limits U.S. filing to ESR1‑mutated...
New research tracking 12.4 million newborns shows the hepatitis B birth‑dose vaccination rate dropping from 83.5 % in 2023 to 73.2 % by mid‑2025, meaning roughly 400,000 infants each year are refusing or delaying the shot. The decline coincides with the CDC’s January decision...
Researchers have engineered a recyclable magnetic nanosystem (Fe3O4/CeO2@BP) that integrates black phosphorus with iron oxide and cerium oxide to achieve rapid, ROS‑driven antibacterial activity in blood. The material can be magnetically retrieved, enabling repeated use across at least 20 disinfection...
LifeVac has secured FDA De Novo classification, designating its suction anti‑choking device as a Class II medical device for second‑line treatment after failed basic life support protocols. The clearance confirms the device as a single‑use, non‑powered, non‑invasive tool suitable for adults and...
Aisa Pharma announced positive Phase II data for AISA‑021, a once‑daily calcium channel blocker, in systemic sclerosis‑associated Raynaud’s phenomenon (SSc RP). The double‑blind, placebo‑controlled RECONNOITER trial enrolled 64 patients and showed a 22.1% reduction in weekly Raynaud attacks and a 155% placebo‑adjusted...
AOK Bayern, one of Germany’s largest statutory health insurers serving 4.5 million members, has migrated its contact‑center operations to NICE CXone on the EU Sovereign Cloud. The move replaces legacy on‑premises systems with a unified, cloud‑native platform that integrates voice, chat, email...
Researchers at Washington University have created a blood‑test model using plasma p‑tau217 that can predict the onset of Alzheimer’s symptoms within three to four years. The model, validated on 603 participants, shows age‑dependent timelines, with younger individuals experiencing longer asymptomatic...
New York’s legislation, signed by Governor Kathy Hochul, shifts the state’s oral‑health model. By mid‑2027, licensed dental hygienists can operate without direct dentist supervision under a collaborative agreement with one dentist. The law also adds foster‑care agencies to approved work...
Health care stakeholders in New York are mobilizing as the state budget negotiations intensify, with the Associated Medical Schools of New York lobbying for an additional $100 million to bolster biomedical research and life‑science jobs. The state already receives over $3.5 billion...
Ipsen is voluntarily withdrawing its EZH2 inhibitor Tazverik worldwide after an interim safety analysis in the phase 1b/3 SYMPHONY‑1 trial linked the drug to secondary hematologic malignancies. The pull‑back includes terminating all ongoing Tazverik studies and recalling the product in markets...
California Governor Gavin Newsom is positioning the state as a national public‑health bulwark by hiring former CDC officials, forming the West Coast Health Alliance with Oregon, Washington and Hawaii, and becoming the first state to join a WHO‑coordinated outbreak network....
Healthcare providers, suppliers, and distributors are tackling fragmented IT systems that impede supply‑chain data sharing. Leaders at Nebraska Medicine, Heartland Dental, and Sinceri Senior Living have implemented procurement interoperability solutions—primarily through Amazon Business integrations—to automate purchase orders, gain real‑time spend...
Healthcare logistics is moving from disposable to circular cold chain packaging, turning boxes into reusable infrastructure. Studies show reusable containers can lower per‑shipment costs by 30‑50% and cut global warming potential by 75%. By engineering packs to reduce dimensional weight,...
Process Performance Qualification (PPQ) is the final validation step before commercial manufacturing of cell and gene therapies, but its complexity often triggers delays and compliance risks. The article highlights three proven strategies—early master‑plan development, continuous quality improvement, and data‑driven analytics—to...
The NHS is moving from a fragmented, market‑led patient‑engagement model to a centrally managed "digital front door" anchored in the NHS App. Funding for the Wayfinder programme will cease in March 2026, saving an estimated £11 million annually and shifting integration directly...
Modern wellness clinics are expanding beyond cosmetic services to include IV hydration therapy as a preventive health option. By delivering fluids, electrolytes, and vitamins directly into the bloodstream, these treatments aim to quickly restore balance for athletes, frequent travelers, and...
Roche’s oral breast‑cancer therapy, touted as a potential blockbuster, missed its primary endpoint in the pivotal Phase 3 persevERA trial. The study evaluated the drug as a first‑line treatment for hormone‑receptor‑positive, HER2‑negative metastatic breast cancer and enrolled more than 1,200 patients...
Hesta Health has opened early access to its postnatal health‑check programme, Recovery, for women in the first six months after birth. The service combines a clinically designed online questionnaire, an at‑home blood test that measures 51 biomarkers across eight domains,...
The NIHR HealthTech Research Centre in Exeter and Sanome have secured a £300,000 Innovate UK SMART grant to advance MEMORI, an AI‑driven clinical decision support platform that predicts hospital‑acquired infections up to seven days before symptoms appear. Early trials show...
Under the Trump administration, the U.S. government slashed nearly $500 million in mRNA research funding, canceling 22 projects and a $766 million Moderna contract. The FDA’s initial refusal then reversal to review Moderna’s flu vaccine highlighted regulatory skepticism toward the platform. Private‑sector...
USC’s Alfred E. Mann School of Pharmacy will open its first community pharmacy in South Los Angeles next month, located beside the T.H.E. Health and Wellness Center in Hyde Park. The modest launch will start with three staff members and expand...
Seoul’s municipal government announced plans to expand its pool of medical‑tourism interpreter‑coordinators to roughly 1,000 this year, a ten‑fold jump from the current cadre. The expansion follows a newly signed memorandum of understanding with the K‑Medical Tourism Association, which will...
IV vitamin therapy is gaining popularity as a wellness service that delivers nutrients directly into the bloodstream, bypassing the digestive system. Proponents claim benefits such as improved mental clarity, fatigue reduction, and immune support, while critics point to limited high‑quality...
Pacemakers and implantable cardioverter defibrillators (ICDs) are small, sub‑cutaneous devices that correct abnormal heart rhythms, but they operate differently. Pacemakers deliver mild electrical pulses to keep a slow or irregular heartbeat steady, while ICDs monitor for rapid, life‑threatening arrhythmias and...
Kristof De Smedt, a veteran with over 25 years in pharma logistics, was promoted on October 1 2025 to Global Market Segment Director for Airlines and Logistic Providers at Cold Chain Technologies (CCT) following its acquisitions of Tower Cold Chain and Global...
A European Migraine and Headache Alliance survey of 5,410 women revealed major gaps in diagnosing and treating hormonally linked migraine. Forty‑two percent of respondents had never received a formal diagnosis, and 35% reported that doctors never discussed their symptoms. While...
Singapore’s Ministry of Health unveiled three new measures to curb rising healthcare costs as the nation becomes a super‑aged society. From 2027, MediSave withdrawal limits will rise to S$700 for basic chronic care and S$1,000 for complex cases, while the...
Researchers at Emory University used artificial intelligence to evaluate arterial calcium visible on routine mammograms, linking it to future cardiovascular events. The study examined 123,762 women without prior heart disease and found that mild, moderate, and severe breast arterial calcification...
Epic Systems has launched a series of lawsuits targeting patent trolls and other entities it deems harmful to the healthcare software ecosystem. The company’s legal offensive seeks injunctions and damages to safeguard its multi‑billion‑dollar portfolio. Simultaneously, industry observers note a...
NHS England has temporarily stopped new prescriptions of cross‑sex hormones for 16‑ and 17‑year‑olds after an evidence review deemed the existing research on benefits and harms “really weak.” The pause applies only to new cases; current patients will continue treatment...
NHS England has temporarily stopped issuing new cross‑sex hormone prescriptions to 16‑ and 17‑year‑olds after an independent review deemed the existing evidence on benefits and harms "remarkably weak." The pause applies only to NHS‑funded care; patients already on treatment will...
Presbyterian Healthcare Services in New Mexico is expanding its use of GW RhythmX’s AI‑powered precision‑care platform, now deployed with 200 primary‑care clinicians across its nine‑hospital system. The tool, embedded in the Epic EHR, surfaces clinical insights and evidence‑based recommendations at...
Healthdirect Australia has launched a Patient Consult Summary (PCS) application within its video‑call platform, which handles more than 150,000 virtual consultations each month. The tool lets clinicians create and share concise, plain‑English summaries instantly via typing, speech‑to‑text, or copy‑paste, and...
The Hong Kong Polytechnic University and the University of Toronto have signed a memorandum of understanding to launch a Joint Research Centre on Healthy Ageing and AgeTech. The centre will conduct cross‑border pilots in hospitals, long‑term care homes and community...
Biodesix reported fiscal 2025 revenue of $88.5 million, a 4,124 % year‑over‑year increase driven largely by its lung‑diagnostics business. Gross margins rose to 83 % in Q4 and the company posted its first positive adjusted EBITDA of $530 k. A strengthened balance sheet now...
Zevra Therapeutics reported Q3 2025 net revenue of $26.1 million, driven primarily by $22.4 million from its FDA‑approved NPC therapy MyPlayFa. The company narrowed its net loss to $0.5 million, a dramatic improvement from a $33.2 million loss a year earlier, while cash and...
Editas Medicine reported Q2 2024 progress on its gene‑edited cell therapy reni‑cel, presenting interim data from the RUBY sickle‑cell and EdiTHAL beta‑thalassemia trials. All 18 RUBY patients were free of vaso‑occlusive events, with hemoglobin levels above 14 g/dL and fetal hemoglobin exceeding...
Researchers have engineered a dual‑stimuli‑responsive nanoparticle that activates the STING pathway only when both acidic pH and hypoxic NQO1 activity are present, creating an AND‑logic release of the agonist MSA‑2. In preclinical models of lung carcinoma, triple‑negative breast cancer and...
